Prior studies regarding the association of ALT with HCC in type 2 diabetic patients are limited, and most of them had been conducted in general population [17, 18] or on individuals with cirrhosis [19], HBV [8, 9, 20], or HCV infections [21] who are at high risk. This evidence concerns the gene GPT and hepatocellular carcinoma.